Clinical research is advancing quickly, but scientific momentum is colliding with persistent operational constraints. Medrio founder and CEO Mike Novotny points to funding cycles, growing study complexity and fragmented technology as forces that can slow progress, particularly for small and midsize life sciences companies.
Trial teams may need to connect EDC, ePRO, RTSM, CTMS and eTMF tools through integrations, spreadsheets and manual processes. Novotny explains why Medrio is building a more unified product suite, with the goal of making trial technology more seamless and giving teams better access to the information they need across a study.
He also discusses Medrio’s customer-listening approach and early adopter program, including how customer feedback is helping shape its CTMS. Watch the full interview to learn more about the forces reshaping clinical research and the role connected technology can play in managing increasing complexity.